Fujita H, Sugiura S, Momomura S, Omata M, Sugi H, Sutoh K
Second Department of Internal Medicine, University of Tokyo, Hongo, Japan.
J Clin Invest. 1997 Mar 1;99(5):1010-5. doi: 10.1172/JCI119228.
Recent studies have revealed that familial hypertrophic cardiomyopathy (FHC) is caused by missence mutations in myosin heavy chain or other sarcomeric proteins. To investigate the functional impact of FHC mutations in myosin heavy chain, mutants of Dictyostelium discoideum myosin II equivalent to human FHC mutations were generated by site-directed mutagenesis, and their motor function was characterized at the molecular level. These mutants, i.e., R397Q, F506C, G575R, A699R, K703Q, and K703W are respectively equivalent to R403Q, F513C, G584R, G716R, R719Q, and R719W FHC mutants. We measured the force generated by these myosin mutants as well as the sliding velocity and the actin-activated ATPase activity. These measurements showed that the A699R, K703Q, and K703W myosins exhibited unexpectedly weak affinity with actin and the lowest level of force, though their ATPase activity remained rather high. F506C mutant which has been reported to have benign prognosis exhibited the least impairment of the motile and enzymatic activities. The motor functions of R397Q and G575R myosins were classified as intermediate. These results suggest that the force level of mutant myosin molecule may be one of the key factors for pathogenesis which affect the prognosis of human FHC.
最近的研究表明,家族性肥厚型心肌病(FHC)是由肌球蛋白重链或其他肌节蛋白中的错义突变引起的。为了研究FHC突变对肌球蛋白重链功能的影响,通过定点诱变产生了与人类FHC突变等效的盘基网柄菌肌球蛋白II突变体,并在分子水平上对其运动功能进行了表征。这些突变体,即R397Q、F506C、G575R、A699R、K703Q和K703W分别等同于R403Q、F513C、G584R、G716R、R719Q和R719W FHC突变体。我们测量了这些肌球蛋白突变体产生的力以及滑动速度和肌动蛋白激活的ATP酶活性。这些测量结果表明,A699R、K703Q和K703W肌球蛋白与肌动蛋白的亲和力出乎意料地弱,力的水平最低,尽管它们的ATP酶活性仍然相当高。据报道预后良好的F506C突变体在运动和酶活性方面的损伤最小。R397Q和G575R肌球蛋白的运动功能被归类为中等。这些结果表明,突变肌球蛋白分子的力水平可能是影响人类FHC预后的发病机制的关键因素之一。